Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: principles and potential

S S Taneja1, S Pang, P Cohan

  • 1Department of Surgery, UCLA School of Medicine 90024-1738, USA.

Cancer Surveys
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stimulated Raman Histology Interpretation by Artificial Intelligence Provides Near-Real-Time Pathologic Feedback for Unprocessed Prostate Biopsies.

The Journal of urology·2023
Same author

[Risk factors and chemoprophylaxis of ulcerative colitis-colorectal cancer].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2022
Same author

[Predicting value on short-term outcome of various established risk prediction models in extracorporeal membrane oxygenation treated cardiogenic shock patients due to ST-segment elevation myocardial infarction].

Zhonghua xin xue guan bing za zhi·2022
Same author

[Early effect of extracorporeal membrane oxygenation and factors related to early outcome in adult patients with fulminant myocarditis].

Zhonghua xin xue guan bing za zhi·2022
Same author

The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2022
Same author

Long noncoding RNA OIP5-AS1 exhibits oncogenic activity in bladder cancer through miR-217 and MTDH.

European review for medical and pharmacological sciences·2021
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Gene therapy offers a novel approach to treating prostate cancer by genetically modifying cancer cells. Careful planning and understanding tumor biology are crucial for successful gene therapy interventions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy presents a novel strategy for treating human malignancies, including prostate cancer.
  • Understanding cancer cell growth and regulation mechanisms provides targets for genetic intervention.
  • Current gene therapy applications for prostate cancer are in early developmental stages.

Purpose of the Study:

  • To explore the potential of gene therapy in treating prostate cancer.
  • To discuss the role of gene transfer vectors in cancer treatment.
  • To highlight the importance of selecting appropriate genes and tailoring strategies for effective intervention.

Main Methods:

  • Utilizing replication-deficient adenoviral and retroviral vectors for gene transfer into cancer cells.

Related Experiment Videos

  • Investigating various genes capable of modifying prostate cancer cell behavior.
  • Considering both ex vivo and in vivo gene therapy approaches.

    • Main Results:

    • Gene therapy holds promise for altering the biological behavior of prostate cancer cells.
    • Adenoviral and retroviral vectors enable consistent gene transfer into target cells.
    • The choice of gene therapy strategy depends on the desired therapeutic outcome and disease stage.

    Conclusions:

    • Successful gene therapy for prostate cancer requires a deep understanding of tumor biology.
    • Tailored gene therapy strategies are essential for treating both localized and metastatic disease.
    • Further research and comprehensive planning are vital for advancing prostate cancer gene therapy.